TLR9 and triple-negative breast carcinoma: While MΦ were not included in Mella’s study, their research suggested that tumorigenic TLR9 and tumor-infiltrating CD8+ T-cells do not correlate with triple-negative breast cancer (TNBC) patient cohort.